Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case–control study

Fig. 2

Commonly-used medications and acute CVEs. Usage of SABA, SAMA, ICS here included either aerosol inhalation or specialized commercial agents. CVEs, cardiovascular events; SABA, short-acting beta agonist; SAMA, short-acting muscarinic antagonist; LABA, long-acting beta agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled glucocorticoid. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us